Placenta
Volume 28 , Pages S4-S13 , April 2007

Gabor Than Award Lecture 2006: Pre-Eclampsia and Villous Trophoblast Turnover: Perspectives and Possibilities

  • I. Crocker

      Affiliations

    • Corresponding Author InformationMaternal and Fetal Health Research Centre, St Mary's Hospital, Hathersage Road, Manchester M13 0JH, UK. Tel.: +44 (0)161 276 5462; fax: +44 (0)161 276 6134.

,Accepted 26 January 2007.

References 

  1. Myers JE, Brockelsby J. The epidemiology of pre-eclampsia. In:  Baker PN,  Kingdom JCP editor. Pre-eclampsia: current perspectives on management. London: Parthenon; 2004;
  2. Redman CW, Sacks GP, Sargent IL. Preeclampsia: an excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol. 1999;180:499–506
  3. Chun D, Braga C, Chow C, Lok L. Clinical observations on some aspects of hydatidiform moles. J Obstet Gynaecol Br Commonw. 1964;71:180–184
  4. Johansen M, Redman CW, Wilkins T, Sargent IL. Trophoblast deportation in human pregnancy—its relevance for pre-eclampsia. Placenta. 1999;20:531–539
  5. Redman CW, Sargent IL. Placental debris, oxidative stress and pre-eclampsia. Placenta. 2000;21:597–602
  6. Knight M, Redman CW, Linton EA, Sargent IL. Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies. Br J Obstet Gynaecol. 1998;105:632–640
  7. Sargent IL, Germain SJ, Sacks GP, Kumar S, Redman CW. Trophoblast deportation and the maternal inflammatory response in pre-eclampsia. J Reprod Immunol. 2003;59:153–160
  8. Schrocksnadel H, Daxenbichler G, Artner E, Steckel-Berger G, Dapunt O. Tumor markers in hypertensive disorders of pregnancy. Gynecol Obstet Invest. 1993;35:204–208
  9. Lo YM, Leung TN, Tein MS, Sargent IL, Zhang J, Lau TK, et al. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem. 1999;45:184–188
  10. Tjoa ML, Oudejans CB, van Vugt JM, Blankenstein MA, van Wijk IJ. Markers for presymptomatic prediction of preeclampsia and intrauterine growth restriction. Hypertens Pregnancy. 2004;23:171–189
  11. Sakuragi N, Ishikura H, Hareyama H, Takeda N, Hirahatake K, Ohkouchi T, et al. Apoptosis in human trophoblastic cells identified by in situ nick end. Labeling of fragmented DNA. Nippon Sanka Fujinka Gakkai Zasshi. 1994;46:533–534
  12. Huppertz B. Placental villous trophoblast: the altered balance between proliferation and apoptosis triggers pre-eclampsia. J Reproduktionsmed Endokrinol. 2006;3:103–108
  13. Janatpour MJ, Utset MF, Cross JC, Rossant J, Dong J, Israel MA, et al. A repertoire of differentially expressed transcription factors that offers insight into mechanisms of human cytotrophoblast differentiation. Dev Genet. 1999;25:146–157
  14. Huppertz B, Bartz C, Kokozidou M. Trophoblast fusion: fusogenic proteins, syncytins and ADAMs, and other prerequisites for syncytial fusion. Micron. 2006;37:509–517
  15. Black S, Kadyrov M, Kaufmann P, Ugele B, Emans N, Huppertz B. Syncytial fusion of human trophoblast depends on caspase 8. Cell Death Differ. 2004;11:90–98
  16. Ka H, Hunt JS. Temporal and spatial patterns of expression of inhibitors of apoptosis in human placentas. Am J Pathol. 2003;163:413–422
  17. Huppertz B, Frank HG, Kingdom JC, Reister F, Kaufmann P. Villous cytotrophoblast regulation of the syncytial apoptotic cascade in the human placenta. Histochem Cell Biol. 1998;110:495–508
  18. Mayhew TM. Villous trophoblast of human placenta: a coherent view of its turnover, repair and contributions to villous development and maturation. Histol Histopathol. 2001;16:1213–1224
  19. Simpson RA, Mayhew TM, Barnes PR. From 13 weeks to term, the trophoblast of human placenta grows by the continuous recruitment of new proliferative units: a study of nuclear number using the disector. Placenta. 1992;13:501–512
  20. Brown LM, Lacey HA, Baker PN, Crocker IP. E-cadherin in the assessment of aberrant placental cytotrophoblast turnover in pregnancies complicated by pre-eclampsia. Histochem Cell Biol. 2005;124:499–506
  21. Mori M, Ishikawa G, Luo SS, Mishima T, Goto T, Robinson JM, et al. The cytotrophoblast layer of human chorionic villi becomes thinner but maintains its structural integrity during gestation. Biol Reprod. 2007;76:164–172
  22. Allaire AD, Ballenger KA, Wells SR, McMahon MJ, Lessey BA. Placental apoptosis in preeclampsia. Obstet Gynecol. 2000;96:271–276
  23. Leung DN, Smith SC, To KF, Sahota DS, Baker PN. Increased placental apoptosis in pregnancies complicated by preeclampsia. Am J Obstet Gynecol. 2001;184:1249–1250
  24. Ishihara N, Matsuo H, Murakoshi H, Laoag-Fernandez JB, Samoto T, Maruo T. Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstet Gynecol. 2002;186:158–166
  25. Arnholdt H, Meisel F, Fandrey K, Lohrs U. Proliferation of villous trophoblast of the human placenta in normal and abnormal pregnancies. Virchows Arch B Cell Pathol Incl Mol Pathol. 1991;60:365–372
  26. Huppertz B, Kingdom JC. Apoptosis in the trophoblast—role of apoptosis in placental morphogenesis. J Soc Gynecol Invest. 2004;11:353–362
  27. Jauniaux E, Watson AL, Hempstock J, Bao YP, Skepper JN, Burton GJ. Onset of maternal arterial blood flow and placental oxidative stress. A possible factor in human early pregnancy failure. Am J Pathol. 2000;157:2111–2122
  28. Jauniaux E, Watson A, Burton G. Evaluation of respiratory gases and acid-base gradients in human fetal fluids and uteroplacental tissue between 7 and 16 weeks’ gestation. Am J Obstet Gynecol. 2001;184:998–1003
  29. Lyall F. Mechanisms regulating cytotrophoblast invasion in normal pregnancy and pre-eclampsia. Aust N Z J Obstet Gynaecol. 2006;46:266–273
  30. James JL, Stone PR, Chamley LW. The regulation of trophoblast differentiation by oxygen in the first trimester of pregnancy. Hum Reprod Update. 2006;12:137–144
  31. Crocker IP, Tansinda DM, Jones CJ, Baker PN. The influence of oxygen and tumor necrosis factor-alpha on the cellular kinetics of term placental villous explants in culture. J Histochem Cytochem. 2004;52:749–757
  32. Kilani RT, Mackova M, Davidge ST, Guilbert LJ. Effect of oxygen levels in villous trophoblast apoptosis. Placenta. 2003;24:826–834
  33. Huppertz B, Kadyrov M, Kingdom JC. Apoptosis and its role in the trophoblast. Am J Obstet Gynecol. 2006;195:29–39
  34. Abumaree MH, Stone PR, Chamley LW. The effects of apoptotic, deported human placental trophoblast on macrophages: possible consequences for pregnancy. J Reprod Immunol. 2006;72:33–45
  35. Chen Q, Stone PR, McCowan LM, Chamley LW. Phagocytosis of necrotic but not apoptotic trophoblasts induces endothelial cell activation. Hypertension. 2006;47:116–121
  36. Hubel CA. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med. 1999;222:222–235
  37. Poston L, Raijmakers MT. Trophoblast oxidative stress, antioxidants and pregnancy outcome—a review. Placenta. 2004;25(Suppl. A):S72–S78
  38. Hung TH, Skepper JN, Burton GJ. In vitro ischemia-reperfusion injury in term human placenta as a model for oxidative stress in pathological pregnancies. Am J Pathol. 2001;159:1031–1043
  39. Tjoa ML, Cindrova-Davies T, Spasic-Boskovic O, Bianchi DW, Burton GJ. Trophoblastic oxidative stress and the release of cell-free feto-placental DNA. Am J Pathol. 2006;169:400–404
  40. Hung TH, Charnock-Jones DS, Skepper JN, Burton GJ. Secretion of tumor necrosis factor-alpha from human placental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in vitro: a potential mediator of the inflammatory response in preeclampsia. Am J Pathol. 2004;164:1049–1061
  41. Zhong XY, Holzgreve W, Hahn S. Circulatory fetal and maternal DNA in pregnancies at risk and those affected by preeclampsia. Ann N Y Acad Sci. 2001;945:138–140
  42. Bloxam DL, Bullen BE, Walters BN, Lao TT. Placental glycolysis and energy metabolism in preeclampsia. Am J Obstet Gynecol. 1987;157:97–101
  43. Schneider H. Placental oxygen consumption. Part II: in vitro studies—a review. Placenta. 2000;21(Suppl. A):S38–S44
  44. Carter AM. Placental oxygen consumption. Part I: in vivo studies—a review. Placenta. 2000;21(Suppl. A):S31–S37
  45. Malek A, Miller RK, Mattison DR, Ceckler T, Panigel M, di Sant'Agnese PA, et al. Continuous measurement of ATP by 31P-NMR in term human dually perfused placenta in vitro: response to ischemia. J Appl Physiol. 1995;78:1778–1786
  46. Illsley NP, Coade SB, Harkness RA. Human placental mitochondrial respiration and its regulation by adenine nucleotides. Placenta. 1985;6:187–197
  47. Seligman SP, Nishiwaki T, Kadner SS, Dancis J, Finlay TH. Hypoxia stimulates ecNOS mRNA expression by differentiated human trophoblasts. Ann N Y Acad Sci. 1997;828:180–187
  48. Crocker IP, Cooper S, Ong SC, Baker PN. Differences in apoptotic susceptibility of cytotrophoblasts and syncytiotrophoblasts in normal pregnancy to those complicated with preeclampsia and intrauterine growth restriction. Am J Pathol. 2003;162:637–643
  49. Crocker IP, Tansinda DM, Baker PN. Altered cell kinetics in cultured placental villous explants in pregnancies complicated by pre-eclampsia and intrauterine growth restriction. J Pathol. 2004;204:11–18
  50. Heazell AEP, Brown LM, Baker PN, Crocker IP. Expression of oncoproteins p53 and Mdm2 within trophoblast of normal and pre-eclamptic pregnancies. J Soc Gynecol Invest. 2005;12:362A
  51. Haupt Y, Maya R, Kazaz A, Oren M. Mdm2 promotes the rapid degradation of p53. Nature. 1997;387:296–299
  52. Meek DW. The p53 response to DNA damage. DNA Repair (Amst). 2004;3:1049–1056
  53. Jones SN, Roe AE, Donehower LA, Bradley A. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature. 1995;378:206–208
  54. Levy R, Smith SD, Chandler K, Sadovsky Y, Nelson DM. Apoptosis in human cultured trophoblasts is enhanced by hypoxia and diminished by epidermal growth factor. Am J Physiol Cell Physiol. 2000;278:C982–C988
  55. Levy R, Smith SD, Yusuf K, Huettner PC, Kraus FT, Sadovsky Y, et al. Trophoblast apoptosis from pregnancies complicated by fetal growth restriction is associated with enhanced p53 expression. Am J Obstet Gynecol. 2002;186:1056–1061
  56. Yusuf K, Smith SD, Levy R, Schaiff WT, Wyatt SM, Sadovsky Y, et al. Thromboxane A(2) limits differentiation and enhances apoptosis of cultured human trophoblasts. Pediatr Res. 2001;50:203–209
  57. Ratts VS, Tao XJ, Webster CB, Swanson PE, Smith SD, Brownbill P, et al. Expression of BCL-2, BAX and BAK in the trophoblast layer of the term human placenta: a unique model of apoptosis within a syncytium. Placenta. 2000;21:361–366
  58. Yamada Z, Kitagawa M, Takemura T, Hirokawa K. Effect of maternal age on incidences of apoptotic and proliferative cells in trophoblasts of full-term human placenta. Mol Hum Reprod. 2001;7:1179–1185
  59. Crocker IP, Barratt S, Kaur M, Baker PN. The in-vitro characterization of induced apoptosis in placental cytotrophoblasts and syncytiotrophoblasts. Placenta. 2001;22:822–830
  60. Hu C, Smith SD, Pang L, Sadovsky Y, Nelson DM. Enhanced basal apoptosis in cultured term human cytotrophoblasts is associated with a higher expression and physical interaction of p53 and Bak. Placenta. 2006;27:978–983
  61. Chen B, Nelson DM, Sadovsky Y. N-myc down-regulated gene 1 modulates the response of term human trophoblasts to hypoxic injury. J Biol Chem. 2006;281:2764
  62. Soleymanlou N, Wu Y, Wang JX, Todros T, Ietta F, Jurisicova A, et al. A novel Mtd splice isoform is responsible for trophoblast cell death in pre-eclampsia. Cell Death Differ. 2005;12:441–452
  63. Yakovlev AG, Di Giovanni S, Wang G, Liu W, Stoica B, Faden AI. BOK and NOXA are essential mediators of p53-dependent apoptosis. J Biol Chem. 2004;279:28367–28374
  64. Teasdale F. Histomorphometry of the human placenta in pre-eclampsia associated with severe intrauterine growth retardation. Placenta. 1987;8:119–128
  65. Mayhew TM, Ohadike C, Baker PN, Crocker IP, Mitchell C, Ong SS. Stereological investigation of placental morphology in pregnancies complicated by pre-eclampsia with and without intrauterine growth restriction. Placenta. 2003;24:219–226
  66. Daayana S, Baker P, Crocker I. An image analysis technique for the investigation of variations in placental morphology in pregnancies complicated by preeclampsia with and without intrauterine growth restriction. J Soc Gynecol Invest. 2004;11:545–552
  67. Fox H. Pathology of the placenta. Philadelphia: Saunders; 1978;p. 208–211
  68. Benirschke K, Kaufmann P, Baergen R. Cases of villous maldevelopment. Pathology of the human placenta. 5th ed.. New York: Springer; 2006;Chapter 15 p. 509–13
  69. Khong TY. Placental vascular development and neonatal outcome. Semin Neonatol. 2004;9:255–263
  70. Fleischer AC, Andreotti RF. Color Doppler sonography in obstetrics and gynecology. Expert Rev Med Devices. 2005;2:605–611
  71. Joern H, Kahn N, Baumann M, Rath W, Schmid-Schoenbein H. Complexity analysis of placental blood flow in normal and high-risk pregnancies. Clin Hemorheol Microcirc. 2002;26:277–293
  72. Brosens IA. Morphological changes in the utero-placental bed in pregnancy hypertension. Clin Obstet Gynaecol. 1977;4:573–593
  73. Kim YM, Bujold E, Chaiworapongsa T, Gomez R, Yoon BH, Thaler HT, et al. Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes. Am J Obstet Gynecol. 2003;189:1063–1069
  74. Craven CM, Morgan T, Ward K. Decidual spiral artery remodelling begins before cellular interaction with cytotrophoblasts. Placenta. 1998;19:241–252
  75. Dixon HG, Robertson WB. A study of the vessels of the placental bed in normotensive and hypertensive women. J Obstet Gynaecol Br Emp. 1958;65:803–809
  76. Sheppard BL, Bonnar J. The ultrastructure of the arterial supply of the human placenta in pregnancy complicated by fetal growth retardation. Br J Obstet Gynaecol. 1976;83:948–959
  77. Robertson WB, Brosens I, Dixon HG. The pathological response of the vessels of the placental bed to hypertensive pregnancy. J Pathol Bacteriol. 1967;93:581–592
  78. Ramsey EM, Corner GW, Donner MW. Serial and cineradioangiographic visualization of maternal circulation on the primate (hemochorial) placenta. Am J Obstet Gynecol. 1963;86:213–225
  79. Crocker IP, Brownbill P, Hutchinson E, Shah M, Sibley CP, Baker PN. Irregular intervillous haemodynamics in the placental pathophysiology of pre-eclampsia. J Soc Gynecol Invest. 2006;13:232A
  80. Crocker IP, Arthur P, Heazell AE, Baker PN. The mitotic manipulation of cytotrophoblast differentiation in vitro. Placenta. 2006;
  81. Yamauchi H, Katayama K, Ueno M, Uetsuka K, Nakayama H, Doi K. Involvement of p53 in 1-beta-D-arabinofuranosylcytosine-induced trophoblastic cell apoptosis and impaired proliferation in rat placenta. Biol Reprod. 2004;70:1762–1767
  82. Baker J, Liu JP, Robertson EJ, Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell. 1993;75:73–82
  83. Sibley CP, Turner MA, Cetin I, Ayuk P, Boyd CA, D'Souza SW, et al. Placental phenotypes of intrauterine growth. Pediatr Res. 2005;58:827–832
  84. Abu-Amero SN, Ali Z, Bennett P, Vaughan JI, Moore GE. Expression of the insulin-like growth factors and their receptors in term placentas: a comparison between normal and IUGR births. Mol Reprod Dev. 1998;49:229–235
  85. Dakour J, Li H, Chen H, Morrish DW. EGF promotes development of a differentiated trophoblast phenotype having c-myc and junB proto-oncogene activation. Placenta. 1999;20:119–126
  86. Garcia-Lloret MI, Yui J, Winkler-Lowen B, Guilbert LJ. Epidermal growth factor inhibits cytokine-induced apoptosis of primary human trophoblasts. J Cell Physiol. 1996;167:324–332
  87. Perkins J, St John J, Ahmed A. Modulation of trophoblast cell death by oxygen and EGF. Mol Med. 2002;8:847–856
  88. Woo YJ, Raju GP, Swain JL, Richmond ME, Gardner TJ, Balice-Gordon RJ. In utero cardiac gene transfer via intraplacental delivery of recombinant adenovirus. Circulation. 1997;96:3561–3569
  89. Xing A, Boileau P, Cauzac M, Challier JC, Girard J, Hauguel-de Mouzon S. Comparative in vivo approaches for selective adenovirus-mediated gene delivery to the placenta. Hum Gene Ther. 2000;11:167–177
  90. Miller AG, Aplin JD, Westwood M. Adenovirally mediated expression of insulin-like growth factors enhances the function of first trimester placental fibroblasts. J Clin Endocrinol Metab. 2005;90:379–385

PII: S0143-4004(07)00030-6

doi: 10.1016/j.placenta.2007.01.016

Placenta
Volume 28 , Pages S4-S13 , April 2007

Article Tools

* Image Usage & Resolution